Omega-3 polyunsaturated fatty acid and insulin sensitivity: A meta-analysis of randomized controlled trials

Clinical Nutrition

Volumn 30, Issue 6, 2011, Pages 702-707

  Akinkuolie, Akintunde O ^a   Ngwa, Julius S ^a   Meigs, James B ^b,c   Djoussé, Luc ^c,d,e  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e VA BOSTON HEALTHCARE SYSTEM   (United States)

Author keywords

Diabetes; Insulin sensitivity; Meta analysis; Omega 3 polyunsaturated fatty acids; Randomized controlled trials

Indexed keywords

FISH OIL; GLUCOSE; INSULIN; OMEGA 3 FATTY ACID;

ADULT; AGED; FAT INTAKE; FEMALE; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; RISK REDUCTION; SYSTEMATIC REVIEW; THERAPY EFFECT; TREATMENT DURATION;

FATTY ACIDS, OMEGA-3; GLUCOSE; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 82255179405     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2011.08.013     Document Type: Review

References (58)

1. Psota T.L., Gebauer S.K., Kris-Etherton P. Dietary omega-3 fatty acid intake and cardiovascular risk. Am J Cardiol 2006 Aug 21, 98(4A):3i-18i. [Epub 2006 May 30].
2. Balk E.M., Lichtenstein A.H., Chung M., Kupelnick B., Chew P., Lau J. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 2006 Nov, 189(1):19-30. [Epub 2006 Mar 10].
3. Harris W.S. n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997, 65(suppl):1645S-1654S.
4. Geleijnse J.M., Giltay E.J., Grobbee D.E., Donders A.R., Kok F.J. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens 2002 Aug, 20(8):1493-1499.
5. Buckley J.D., Howe P.R. Anti-obesity effects of long-chain omega-3 polyunsaturated fatty acids. Obes Rev 2009 Nov, 10(6):648-659. [Epub 2009 May 12].
6. James M.J., Gibson R.A., Cleland L.G. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 2000 Jan, 71(1 Suppl):343S-348S.
7. Madsen T., Skou H.A., Hansen V.E., Fog L., Christensen J.H., Toft E., et al. C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease. Am J Cardiol 2001 Nov 15, 88(10):1139-1142.
8. Endres S., Ghorbani R., Kelley V.E., Georgilis K., Lonnemann G., van der Meer J.W., et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989 Feb 2, 320(5):265-271.
9. Schectman G., Kaul S., Kissebah A.H. Effect of fish oil concentrate on lipoprotein composition in NIDDM. Diabetes 1988 Nov, 37(11):1567-1573.
10. Glauber H., Wallace P., Griver K., Brechtel G. Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus. Ann Intern Med 1988 May, 108(5):663-668.
11. Moloney F., Yeow T.P., Mullen A., Nolan J.J., Roche H.M. Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. Am J Clin Nutr 2004 Oct, 80(4):887-895.
12. Risérus U., Arner P., Brismar K., Vessby B. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 2002 Sep, 25(9):1516-1521.
13. Friedberg C.E., Janssen M.J., Heine R.J., Grobbee D.E. Fish oil and glycemic control in diabetes. A meta-analysis. Diabetes Care 1998 Apr, 21(4):494-500.
14. Puhakainen I., Ahola I., Yki-Järvinen H. Dietary supplementation with n-3 fatty acids increases gluconeogenesis from glycerol but not hepatic glucose production in patients with non-insulin-dependent diabetes mellitus. Am J Clin Nutr 1995 Jan, 61(1):121-126.
15. Annuzzi G., Rivellese A., Capaldo B., Di Marino L., Iovine C., Marotta G., et al. A controlled study on the effects of n-3 fatty acids on lipid and glucose metabolism in non-insulin-dependent diabetic patients. Atherosclerosis 1991 Mar, 87(1):65-73.
16. Luo J., Rizkalla S.W., Vidal H., Oppert J.M., Colas C., Boussairi A., et al. Moderate intake of n-3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men. Results of a controlled study. Diabetes Care 1998 May, 21(5):717-724.
17. Li C., Ford E.S., McGuire L.C., Mokdad A.H., Little R.R., Reaven G.M. Trends in hyperinsulinemia among nondiabetic adults in the U.S. Diabetes Care 2006 Nov, 29(11):2396-2402.
18. Moller D.E., Flier J.S. Insulin resistance-mechanisms, syndromes, and implications. N Engl J Med 1991 Sep 26, 325(13):938-948.
19. DeFronzo R.A., Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991 Mar, 14(3):173-194.
20. Petersen K.F., Dufour S., Savage D.B., Bilz S., Solomon G., Yonemitsu S., et al. The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci U S A 2007 Jul 31, 104(31):12587-12594. [Epub 2007 Jul 18].
21. Cochrane handbook for systematic reviews of interventions version 5.0.2 [updated September 2009] 2009, The Cochrane Collaboration, Available from:, [accessed through 1.10.2010 and 6.12.2010]. http://www.cochrane-handbook.org, J.P.T. Higgins, S. Green (Eds.).
22. Muniyappa R., Lee S., Chen H., Quon M.J. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008 Jan, 294(1):E15-E26. [Epub 2007 Oct 23].
23. Lefebvre C., Manheimer E., Glanville J. Chapter 6: searching for studies. Cochrane handbook for systematic reviews of interventions version 5.0.2 (updated September 2009) 2009, The Cochrane Collaboration, Available from:, [accessed 6.10.2010]. http://www.cochrane-handbook.org, J.P.T. Higgins, S. Green (Eds.).
24. Wong S.S., Wilczynski N.L., Haynes R.B. Developing optimal search strategies for detecting clinically sound treatment studies in EMBASE. J Med Lib Assoc 2006, 94:41-47.
25. Giacco R., Cuomo V., Vessby B., Uusitupa M., Hermansen K., Meyer B.J., et al. Fish oil, insulin sensitivity, insulin secretion and glucose tolerance in healthy people: is there any effect of fish oil supplementation in relation to the type of background diet and habitual dietary intake of n-6 and n-3 fatty acids?. Nutr Metab Cardiovasc Dis 2007 Oct, 17(8):572-580. KANWU Study Group, [Epub 2006 Nov 28].
26. Mostad I.L., Bjerve K.S., Bjorgaas M.R., Lydersen S., Grill V. Effects of n-3 fatty acids in subjects with type 2 diabetes: reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidation. Am J Clin Nutr 2006 Sep, 84(3):540-550.
27. Chapter 8: assessing risk of bias in included studies. Cochrane handbook for systematic reviews of interventions version 5.0.1 (updated September 2008) 2008, The Cochrane Collaboration, Available from:, [accessed 15.11.2010]. http://www.cochrane-handbook.org, J.P.T. Higgins, D.G. Altman, J.P.T. Higgins, S. Green (Eds.).
28. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trial 1986, 7:177-188.
29. Chapter 7: selecting studies and collecting data. Cochrane handbook for systematic reviews of interventions version 5.0.1 (updated September 2008) 2008, The Cochrane Collaboration, Available from:. http://www.cochrane-handbook.org, J.P.T. Higgins, J.J. Deeks, J.P.T. Higgins, S. Green (Eds.).
30. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
31. Egger M., Smith G.D., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
32. Schünemann H.J., Oxman A.D., Vist G.E., Higgins J.P.T., Deeks J.J., Glasziou P., et al. Chapter 12: interpreting results and drawing conclusions. Cochrane handbook for systematic reviews of interventions version 5.0.1 (updated September 2008) 2008, The Cochrane Collaboration, Available from:. http://www.cochrane-handbook.org, Higgins JPT, Green S (Eds.).
33. Lee S., Choi S., Kim H.J., Chung Y.S., Lee K.W., Lee H.C., et al. Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults. J Korean Med Sci. 2006 Aug, 21(4):695-700.
34. Hrebícek J., Janout V., Malincíková J., Horáková D., Cízek L. Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention. J Clin Endocrinol Metab 2002 Jan, 87(1):144-147.
35. Rizza S., Tesauro M., Cardillo C., Galli A., Iantorno M., Gigli F., et al. Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetes. Atherosclerosis 2009 Oct, 206(2):569-574. [Epub 2009 Mar 19].
36. Olza J., Mesa M.D., Aguilera C.M., Moreno-Torres R., Jiménez A., Pérez de la Cruz A., et al. Influence of an eicosapentaenoic and docosahexaenoic acid-enriched enteral nutrition formula on plasma fatty acid composition and biomarkers of insulin resistance in the elderly. Clin Nutr 2010 Feb, 29(1):31-37. [Epub 2009 Jul 1].
37. Woodman R.J., Mori T.A., Burke V., Puddey I.B., Watts G.F., Beilin L.J. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr 2002 Nov, 76(5):1007-1015.
38. Calder P.C., Yaqoob P. Understanding omega-3 polyunsaturated fatty acids. Postgrad Med 2009 Nov, 121(6):148-157.
39. Review Manager (RevMan) [Computer program]. Version 5.0 2008, The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen.
40. Toft I., Bønaa K.H., Ingebretsen O.C., Nordøy A., Jenssen T. Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trial. Ann Intern Med 1995 Dec 15, 123(12):911-918.
41. Pedersen M.H., Mølgaard C., Hellgren L.I., Lauritzen L. Effects of fish oil supplementation on markers of the metabolic syndrome. Pediatr 2010 Sep, 157(3):395-400. 400.e1. Epub 2010 May 15.
42. Kabir M., Skurnik G., Naour N., Pechtner V., Meugnier E., Rome S., et al. Treatment for 2 mo with n 3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study. Am J Clin Nutr 2007 Dec, 86(6):1670-1679.
43. Spadaro L., Magliocco O., Spampinato D., Piro S., Oliveri C., Alagona C., et al. Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease. Dig Liver Dis 2008 Mar, 40(3):194-199. Epub 2007 Dec 4.
44. Nelson T.L., Stevens J.R., Hickey M.S. Adiponectin levels are reduced, independent of polymorphisms in the adiponectin gene, after supplementation with alpha-linolenic acid among healthy adults. Metabolism 2007 Sep, 56(9):1209-1215.
45. Abete I., Parra D., Crujeiras A.B., Goyenechea E., Martinez J.A. Specific insulin sensitivity and leptin responses to a nutritional treatment of obesity via a combination of energy restriction and fatty fish intake. J Hum Nutr Diet 2008 Dec, 21(6):591-600. [Epub 2008 Aug 27].
46. Hartweg J., Perera R., Montori V.M., Dinneen S.F., Neil A.H.A.W.N., Farmer A.J. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus 2008, Cochrane Database of Systematic Reviews, Issue 1. Art. No.: CD003205. 10.1002/14651858.CD003205.pub2.
47. Kahn B.B. Lilly lecture 1995. Glucose transport: pivotal step in insulin action. Diabetes 1996 Nov, 45(11):1644-1654.
48. Pontiroli A.E., Monti L.D., Costa S., Sandoli P.E., Pizzini A., Solerte S.B., et al. In middle-aged siblings of patients with type 2 diabetes mellitus normal glucose tolerance is associated with insulin resistance and with increased insulin secretion. The SPIDER study. Eur J Endocrinol 2000 Nov, 143(5):681-686.
49. Pimenta W.P., Santos M.L., Cruz N.S., Aragon F.F., Padovani C.R., Gerich J.E. Insulin secretion, insulin sensitivity, and hepatic insulin extraction in first-degree relatives of type 2 diabetic patients. Braz J Med Biol Res 2003 Mar, 36(3):301-308. [Epub 2003 Mar 7].
50. Vaag A., Henriksen J.E., Madsbad S., Holm N., Beck-Nielsen H. Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. J Clin Invest 1995, 95:690-698.
51. Montori V.M., Farmer A., Wollan P.C., Dinneen S.F. Fish oil supplementation in type 2 diabetes: a quantitative systematic review. Diabetes Care 2000 Sep, 23(9):1407-1415. [Review].
52. Wang L., Folsom A.R., Zheng Z.J., Pankow J.S., Eckfeldt J.H. ARIC Study Investigators. Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 2003 Jul, 78(1):91-98.
53. Laaksonen D.E., Lakka T.A., Lakka H.M., Nyyssönen K., Rissanen T., Niskanen L.K., et al. Serum fatty acid composition predicts development of impaired fasting glycaemia and diabetes in middle-aged men. Diabet Med 2002 Jun, 19(6):456-464.
54. Hodge A.M., English D.R., O'Dea K., Sinclair A.J., Makrides M., Gibson R.A., et al. Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid. Am J Clin Nutr 2007 Jul, 86(1):189-197.
55. Djoussé L., Biggs M.L., Lemaitre R.N., King I.B., Song X., Ix J.H., et al. Plasma omega-3 fatty acids and incident diabetes in older adults. Am J Clin Nutr 2011 May 18, [Epub ahead of print].
56. Kaushik M., Mozaffarian D., Spiegelman D., Manson J.E., Willett W.C., Hu F.B. Long-chain omega-3 fatty acids, fish intake, and the risk of type 2 diabetes mellitus. Am J Clin Nutr 2009 Sep, 90(3):613-620. [Epub 2009 Jul 22].
57. Djoussé L., Gaziano J.M., Buring J.E., Lee I.M. Dietary omega-3 fatty acids and fish consumption and risk of type 2 diabetes. Am J Clin Nutr 2011 Jan, 93(1):143-150. [Epub 2010 Oct 27].
58. Brostow D.P., Odegaard A.O., Koh W.P., Duval S., Gross M.D., Yuan J.M., et al. Omega-3 fatty acids and incident type 2 diabetes: the Singapore Chinese Health Study. Am J Clin Nutr 2011 May 18, [Epub ahead of print].